Cogstate Share Price and Company Fundamentals
Last traded: Last Friday at 6:10 AM
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. As of June 30, 2021, it had participated in approximately 1,800 academic research studies in approximately 200 indications. Cogstate Limited was incorporated in 1999 and is based in Fitzroy, Australia.
|Primary activities||Cogstate Ltd (ASX:CGS) is a leading neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Cogstate technologies provide rapid, reliable and hi|
|Industry / Sector||Health Information Services / Healthcare|
|Mailing address||425 Smith Street Suite 117 Fitzroy VIC 3065 Australia|
|Phone / Fax||61 3 9664 1300 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Cogstate does not pay dividends.
As of Sep 2021, following are the company executives and directors listed on Cogstate.
|Mr. Bradley O'Connor C.A., B.Bus, CA||CEO, MD & Exec. Director||949.49k|
|Prof. Paul Maruff BBSc (Hons), Ph.D.||Founder & Chief Innovation Officer||566.2k|
|Mr. Darren Watson||Chief Financial Officer||371.24k|
|Mr. Benjamin Bloomfield||Chief Technology Officer||380.83k|
|Mr. Kenneth Billard||Chief Commercial Officer||592.61k|
|Dr. Chris Edgar Ph.D.||Chief Science Officer|
|Ms. Rachel Colite||VP of Strategic Initiatives, Communication & People|
|Mr. David James Franks B.Ec, BEc, CA, F Fin, JP.||Company Sec.||50|
|Dr. Amy E. Veroff Ph.D.||Principal Consultant|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Cogstate is 361.95M and its enterprise value is 337.18M. The enterprise value to revenue ratio of CGS is 10.31.
Companies similar to Cogstate (CGS)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Cogstate (ASX:CGS) Frequently Asked Questions
1. What is Cogstate's Stock Symbol?
Cogstate trades on ASX under the ticker symbol "CGS".
2. What is Cogstate's stock price today?
One share of CGS stock can currently be purchased for approximately $2.1.
3. How can I contact Cogstate?
Cogstate's mailing address is 425 Smith Street Suite 117 Fitzroy VIC 3065 Australia. The company can be reached via phone at 61 3 9664 1300.
4. What is Cogstate's official website?
The official website of Cogstate is http://www.cogstate.com.
5. Which share registry manages Cogstate's stock?
Cogstate's stock is managed by LINK MARKET SERVICES LIMITED.